InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.670
+0.060 (3.73%)
At close: Apr 28, 2026, 4:00 PM EDT
1.670
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:59 PM EDT
InflaRx Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for InflaRx stock have an average target of 7.00, with a low estimate of 2.00 and a high estimate of 14. The average target predicts an increase of 319.16% from the current stock price of 1.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for InflaRx stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +738.32% | Apr 21, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $22 → $14 | Strong Buy | Maintains | $22 → $14 | +738.32% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +259.28% | Dec 30, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $5 → $2 | Buy → Hold | Downgrades | $5 → $2 | +19.76% | Dec 3, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $10 → $22 | Strong Buy | Maintains | $10 → $22 | +1,217.37% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
16.62K
from 29.33K
Decreased by -43.35%
Revenue Next Year
16.62K
from 16.62K
EPS This Year
-0.50
from -0.68
EPS Next Year
-0.50
from -0.50
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 87,150 | 85,050 | ||||||
| Avg | 16,616 | 16,616 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 197.1% | 411.9% | ||||||
| Avg | -43.4% | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.40 | -0.34 | ||||||
| Avg | -0.50 | -0.50 | ||||||
| Low | -0.57 | -0.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.